FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313580303> ?p ?o ?g. }

• W4313580303 abstract "Breast cancer susceptibility gene 1 (BRCA1)-associated ovarian cancer patients have been treated with A poly (ADP-ribose) polymerase (PARP) inhibitor, extending the progression-free survival; however, they finally acquire therapeutic resistance. Interleukin (IL)-34 has been reported as a poor prognostic factor in several cancers, including ovarian cancer, and it contributes to the therapeutic resistance of chemotherapies. IL-34 may affect the therapeutic effect of PARP inhibitor through the regulation of tumor microenvironment (TME).In this study, The Cancer Genome Atlas (TCGA) data set was used to evaluate the prognosis of IL-34 and human ovarian serous carcinoma. We also used CRISPR-Cas9 genome editing technology in a mouse model to evaluate the efficacy of PARP inhibitor therapy in the presence or absence of IL-34.We found that IL34 was an independent poor prognostic factor in ovarian serous carcinoma, and its high expression significantly shortens overall survival. Furthermore, in BRCA1-associated ovarian cancer, PARP inhibitor therapy contributes to anti-tumor immunity via the XCR1+ DC-CD8+ T cell axis, however, it is canceled by the presence of IL-34.These results suggest that tumor-derived IL-34 benefits tumors by creating an immunosuppressive TME and conferring PARP inhibitor therapeutic resistance. Thus, we showed the pathological effect of IL-34 and the need for it as a therapeutic target in ovarian cancer." @default.
• W4313580303 created "2023-01-06" @default.
• W4313580303 creator A5004137542 @default.
• W4313580303 creator A5016137471 @default.
• W4313580303 creator A5016421869 @default.
• W4313580303 creator A5025136502 @default.
• W4313580303 creator A5036460159 @default.
• W4313580303 creator A5056700046 @default.
• W4313580303 creator A5063078803 @default.
• W4313580303 creator A5068002438 @default.
• W4313580303 creator A5078219269 @default.
• W4313580303 creator A5089794335 @default.
• W4313580303 date "2023-01-01" @default.
• W4313580303 modified "2023-09-30" @default.
• W4313580303 title "Interleukin-34 cancels anti-tumor immunity by PARP inhibitor" @default.
• W4313580303 cites W1611944043 @default.
• W4313580303 cites W1973268287 @default.
• W4313580303 cites W2023962283 @default.
• W4313580303 cites W2065593489 @default.
• W4313580303 cites W2067117419 @default.
• W4313580303 cites W2083571567 @default.
• W4313580303 cites W2098737737 @default.
• W4313580303 cites W2103452148 @default.
• W4313580303 cites W2127560962 @default.
• W4313580303 cites W2172537925 @default.
• W4313580303 cites W2203467993 @default.
• W4313580303 cites W2289044916 @default.
• W4313580303 cites W2314057593 @default.
• W4313580303 cites W2476568892 @default.
• W4313580303 cites W2500066130 @default.
• W4313580303 cites W2516214053 @default.
• W4313580303 cites W2587333476 @default.
• W4313580303 cites W2732346161 @default.
• W4313580303 cites W2737389832 @default.
• W4313580303 cites W2740637641 @default.
• W4313580303 cites W2767593721 @default.
• W4313580303 cites W2787835497 @default.
• W4313580303 cites W2807028416 @default.
• W4313580303 cites W2808909747 @default.
• W4313580303 cites W2900248192 @default.
• W4313580303 cites W2903718866 @default.
• W4313580303 cites W2905644126 @default.
• W4313580303 cites W2997719022 @default.
• W4313580303 cites W3036841520 @default.
• W4313580303 cites W3043876358 @default.
• W4313580303 cites W3043941778 @default.
• W4313580303 cites W3112241528 @default.
• W4313580303 cites W3134914296 @default.
• W4313580303 cites W3162370541 @default.
• W4313580303 cites W3184202385 @default.
• W4313580303 cites W3208681891 @default.
• W4313580303 cites W3213161841 @default.
• W4313580303 cites W4200215809 @default.
• W4313580303 cites W4225425568 @default.
• W4313580303 doi "https://doi.org/10.3802/jgo.2023.34.e25" @default.
• W4313580303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36603850" @default.
• W4313580303 hasPublicationYear "2023" @default.
• W4313580303 type Work @default.
• W4313580303 citedByCount "1" @default.
• W4313580303 countsByYear W43135803032023 @default.
• W4313580303 crossrefType "journal-article" @default.
• W4313580303 hasAuthorship W4313580303A5004137542 @default.
• W4313580303 hasAuthorship W4313580303A5016137471 @default.
• W4313580303 hasAuthorship W4313580303A5016421869 @default.
• W4313580303 hasAuthorship W4313580303A5025136502 @default.
• W4313580303 hasAuthorship W4313580303A5036460159 @default.
• W4313580303 hasAuthorship W4313580303A5056700046 @default.
• W4313580303 hasAuthorship W4313580303A5063078803 @default.
• W4313580303 hasAuthorship W4313580303A5068002438 @default.
• W4313580303 hasAuthorship W4313580303A5078219269 @default.
• W4313580303 hasAuthorship W4313580303A5089794335 @default.
• W4313580303 hasBestOaLocation W43135803031 @default.
• W4313580303 hasConcept C104317684 @default.
• W4313580303 hasConcept C121608353 @default.
• W4313580303 hasConcept C126322002 @default.
• W4313580303 hasConcept C143998085 @default.
• W4313580303 hasConcept C150173356 @default.
• W4313580303 hasConcept C167672396 @default.
• W4313580303 hasConcept C182979987 @default.
• W4313580303 hasConcept C203014093 @default.
• W4313580303 hasConcept C2776107976 @default.
• W4313580303 hasConcept C2779138821 @default.
• W4313580303 hasConcept C2779256057 @default.
• W4313580303 hasConcept C2780427987 @default.
• W4313580303 hasConcept C3019054536 @default.
• W4313580303 hasConcept C3020616263 @default.
• W4313580303 hasConcept C502942594 @default.
• W4313580303 hasConcept C55493867 @default.
• W4313580303 hasConcept C71924100 @default.
• W4313580303 hasConcept C82381507 @default.
• W4313580303 hasConcept C86803240 @default.
• W4313580303 hasConcept C8891405 @default.
• W4313580303 hasConceptScore W4313580303C104317684 @default.
• W4313580303 hasConceptScore W4313580303C121608353 @default.
• W4313580303 hasConceptScore W4313580303C126322002 @default.
• W4313580303 hasConceptScore W4313580303C143998085 @default.
• W4313580303 hasConceptScore W4313580303C150173356 @default.
• W4313580303 hasConceptScore W4313580303C167672396 @default.
• W4313580303 hasConceptScore W4313580303C182979987 @default.
• W4313580303 hasConceptScore W4313580303C203014093 @default.

• next